Disease presentation, treatment and survival for Italian colorectal cancer patients: A EUROCARE high resolution study

Pamela Minicozzi, Shaniko Kaleci, Stefania Maffei, Claudia Allemani, Adriano Giacomin, Adele Caldarella, Francesco Iachetta, Mario Fusco, Rosario Tumino, Massimo Vicentini, Fabio Falcini, Rosaria Cesaraccio, Maurizio Ponz De Leon, Milena Sant

Research output: Contribution to journalArticle

Abstract

We analysed presentation, treatment and survival in a representative population-based sample of 3753 Italian colorectal cancer cases, diagnosed 2003-05: 70% were >65 years, 44% stage I-II, 27% stage IV and 92% received surgery. Chemotherapy was given to 58% of stage III colon cases, radiotherapy to 25% of rectal cases. Four percent of surgical cases underwent endoscopic polypectomy, and in 57% â 11 lymph nodes were examined. Five-year relative survival was good (60%), independent of sex and site. Adherence to treatment guidelines was satisfactory, but wider use of faecal blood testing and colonoscopy will anticipate stage at diagnosis and likely improve survival.

Original languageEnglish
Pages (from-to)98-100
Number of pages3
JournalEuropean Journal of Public Health
Volume24
Issue number1
DOIs
Publication statusPublished - Feb 1 2013

    Fingerprint

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Minicozzi, P., Kaleci, S., Maffei, S., Allemani, C., Giacomin, A., Caldarella, A., Iachetta, F., Fusco, M., Tumino, R., Vicentini, M., Falcini, F., Cesaraccio, R., De Leon, M. P., & Sant, M. (2013). Disease presentation, treatment and survival for Italian colorectal cancer patients: A EUROCARE high resolution study. European Journal of Public Health, 24(1), 98-100. https://doi.org/10.1093/eurpub/ckt056